Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1
Top Cited Papers
Open Access
- 1 March 2007
- journal article
- Published by Centers for Disease Control and Prevention (CDC) in Emerging Infectious Diseases
- Vol. 13 (3) , 426-435
- https://doi.org/10.3201/eid1303.061125
Abstract
Changes in influenza viruses require regular reformulation of strain-specific influenza vaccines. Vaccines based on conserved antigens provide broader protection. Influenza matrix protein 2 (M2) is highly conserved across influenza A subtypes. To evaluate its efficacy as a vaccine candidate, we vaccinated mice with M2 peptide of a widely shared consensus sequence. This vaccination induced antibodies that cross-reacted with divergent M2 peptide from an H5N1 subtype. A DNA vaccine expressing full-length consensus-sequence M2 (M2-DNA) induced M2-specific antibody responses and protected against challenge with lethal influenza. Mice primed with M2-DNA and then boosted with recombinant adenovirus expressing M2 (M2-Ad) had enhanced antibody responses that cross-reacted with human and avian M2 sequences and induced T-cell responses. This M2 prime-boost vaccination conferred broad protection against challenge with lethal influenza A, including an H5N1 strain. Vaccination with M2, with key sequences represented, may provide broad protection against influenza A.Keywords
This publication has 24 references indexed in Scilit:
- Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoproteinVaccine, 2005
- Evolution of H5N1 Avian Influenza Viruses in AsiaEmerging Infectious Diseases, 2005
- Influenza Type A Virus Escape Mutants Emerge In Vivo in the Presence of Antibodies to the Ectodomain of Matrix Protein 2Journal of Virology, 2005
- Sequence comparison between the extracellular domain of M2 protein human and avian influenza A virus provides new information for bivalent influenza vaccine designMicrobes and Infection, 2005
- Preclinical study of influenza virus A M2 peptide conjugate vaccines in mice, ferrets, and rhesus monkeysVaccine, 2004
- High Frequency of Resistant Viruses Harboring Different Mutations in Amantadine‐Treated Children with InfluenzaThe Journal of Infectious Diseases, 2003
- Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2Vaccine, 2003
- Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M geneVaccine, 2001
- Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 proteinVaccine, 1995
- Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral ProteinScience, 1993